PubRank

H W M Niessen

Author PubWeight™ 30.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Apoptosis in myocardial ischaemia and infarction. J Clin Pathol 2002 1.59
2 C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest 2004 1.50
3 Perivenous application of fibrin glue reduces early injury to the human saphenous vein graft wall in an ex vivo model. Eur J Cardiothorac Surg 2002 1.48
4 Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol 2003 1.25
5 Amyloid in the cardiovascular system: a review. J Clin Pathol 2005 1.24
6 Accumulation of fibronectin in the heart after myocardial infarction: a putative stimulator of adhesion and proliferation of adipose-derived stem cells. Cell Tissue Res 2008 1.01
7 Clusterin: a protective mediator for ischemic cardiomyocytes? Am J Physiol Heart Circ Physiol 2005 1.00
8 Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study. Eur Radiol 2014 1.00
9 Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin. Cell Tissue Res 2008 1.00
10 Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction. J Clin Pathol 2006 0.99
11 Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell Tissue Res 2012 0.97
12 The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study. Br J Cancer 2007 0.95
13 IgM colocalises with complement and C reactive protein in infarcted human myocardium. J Clin Pathol 2005 0.95
14 NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J Clin Pathol 2002 0.90
15 N(epsilon)-(carboxymethyl)lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction? Arterioscler Thromb Vasc Biol 2006 0.87
16 Type II secretory phospholipase A2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death. Am J Physiol Heart Circ Physiol 2003 0.86
17 The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1. Diabetologia 2013 0.85
18 Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice. Br J Cancer 2007 0.85
19 Ischemia induces nuclear NOX2 expression in cardiomyocytes and subsequently activates apoptosis. Apoptosis 2006 0.84
20 Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus. Eur J Endocrinol 2008 0.83
21 Reduction of infarct size by intravenous injection of uncultured adipose derived stromal cells in a rat model is dependent on the time point of application. Stem Cell Res 2011 0.82
22 Therapeutic application of adipose derived stem cells in acute myocardial infarction: lessons from animal models. Stem Cell Rev 2014 0.82
23 Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis. J Clin Pathol 2002 0.79
24 Role of plaque inflammation in acute and recurrent coronary syndromes. Neth Heart J 2004 0.79
25 Pulmonary embolism causes endomyocarditis in the human heart. Heart 2007 0.79
26 The multidrug resistance protein breast cancer resistance protein (BCRP) protects adipose-derived stem cells against ischemic damage. Cell Biol Toxicol 2012 0.79
27 Secretory type II phospholipase A2 in culprit coronary lesions is associated with myocardial infarction. Eur J Clin Invest 2008 0.78
28 Activated complement is more extensively present in diseased aortic valves than naturally occurring complement inhibitors: a sign of ongoing inflammation. Eur J Clin Invest 2009 0.78
29 Topical vascular endothelial growth factor in rabbit tracheal surgery: comparative effect on healing using various reconstruction materials and intraluminal stents. Eur J Cardiothorac Surg 2003 0.77
30 Myocardial air collections as a result of infection with a gas producing strain of Escherichia coli. J Clin Pathol 2004 0.75
31 NAD(P)H oxidase in the failing human heart. J Am Coll Cardiol 2003 0.75
32 C-reactive protein as a pro-inflammatory mediator in cardiovascular disease by its ability to activate complement: additional proof and hypothetical mechanisms. Neth Heart J 2002 0.75
33 Increased infiltration of Chlamydophila pneumoniae in the vessel wall of human veins after perfusion. Eur J Clin Invest 2008 0.75
34 Surgical sealant in the prevention of early vein graft injury in an ex vivo model. Cardiovasc Pathol 2003 0.75